- Home
- PMTS vs ORGO Comparison
PMTS vs ORGO Comparison
Compare PMTS & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- ORGO
- Stock Information
- Founded
- PMTS 2007
- ORGO 1985
- Country
- PMTS United States
- ORGO United States
- Employees
- PMTS N/A
- ORGO N/A
- Industry
- PMTS Finance Companies
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- ORGO Health Care
- Exchange
- PMTS Nasdaq
- ORGO Nasdaq
- Market Cap
- PMTS 327.9M
- ORGO 384.4M
- IPO Year
- PMTS 2015
- ORGO N/A
- Fundamental
- Price
- PMTS $22.95
- ORGO $3.25
- Analyst Decision
- PMTS Strong Buy
- ORGO Buy
- Analyst Count
- PMTS 4
- ORGO 2
- Target Price
- PMTS $36.75
- ORGO $5.50
- AVG Volume (30 Days)
- PMTS 68.1K
- ORGO 853.3K
- Earning Date
- PMTS 08-04-2025
- ORGO 08-07-2025
- Dividend Yield
- PMTS N/A
- ORGO N/A
- EPS Growth
- PMTS 1.33
- ORGO N/A
- EPS
- PMTS 1.58
- ORGO N/A
- Revenue
- PMTS $491,426,000.00
- ORGO $458,760,000.00
- Revenue This Year
- PMTS $14.61
- ORGO $2.62
- Revenue Next Year
- PMTS $12.49
- ORGO $12.46
- P/E Ratio
- PMTS $14.66
- ORGO N/A
- Revenue Growth
- PMTS 12.81
- ORGO 5.35
- 52 Week Low
- PMTS $18.46
- ORGO $2.28
- 52 Week High
- PMTS $35.19
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- PMTS 52.41
- ORGO 48.02
- Support Level
- PMTS $22.61
- ORGO $3.08
- Resistance Level
- PMTS $23.20
- ORGO $3.71
- Average True Range (ATR)
- PMTS 0.82
- ORGO 0.21
- MACD
- PMTS 0.26
- ORGO 0.07
- Stochastic Oscillator
- PMTS 78.73
- ORGO 55.45
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.